Major Shareholding Notification • Dec 7, 2022
Major Shareholding Notification
Open in ViewerOpens in native device viewer

IBA (Ion Beam Applications), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on December 05th 2022.
In its notification, La Société Fédérale de Participations et d'Investissement (SFPI) has notified, that following the passive crossing of a threshold, its total holding in IB SA has crossed upwards the 5% threshold.
Press release | 07/02/ 2022


1

| A) Droits de vote | Notification précédente # droits de vote |
Après la transaction | |||||
|---|---|---|---|---|---|---|---|
| # droits de vote | % de droits de vote | ||||||
| Détenteurs de droits de vote | Attachés à des titres |
Non liés à des titres | Attachés à des titres |
Non liés à des titres |
|||
| L'Etat belge | 0 | 0 | 0 | 0,00% | 0,00% | ||
| La Société Fédérale de Participations et d'Investissement |
58.200 | 58.200 | 0 | 0.15% | 0.00% | ||
| La S.A. Belfius Banque | 0 | 0 | 0 | 0,00% | 0,00% | ||
| La S.A. Belfius Insurance | 903.754 | 2.378.392 | 0 | 6,20% | 0,00% | ||
| Sous-total | 961 954 | 2.436.592 | 6,36% | ||||
| TOTAL | 2.436.592 | 0 | 6,36% | 0,00% |
| B) Instruments financiers assimilés |
Après la transaction | |||||||
|---|---|---|---|---|---|---|---|---|
| Détenteurs d'instruments financiers assimilés |
Type d'instrument financier | Date d'échéance DD/MM/YYYY |
Date ou délai d'exercice ou de conversion DD/MMYYYY ou Texte |
# droits de vote pouvant être acquis en cas d'exercice de l'instrument |
% de droits de vote |
Réglement | ||
| TOTAL | 0 | 0,00% | ||||||
| Les totaux ne seront mis à jour qu'après avoir utilisé la touche |
||||||||
| TOTAL (A & B) | # de droits de vote |
% de droits de vote |
||||||
| CALCULER | 2.436.592 | 6,36% |
La Société Fédérale de Participations et d'Investissement (SFPI-FPMI) acting in its own name but on behalf of the Belgian State, owns Belfius Bank S.A., which in turn is the parent company of the parent company of the S.A.
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,800 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
Press release | 07/02/ 2022

IBA | Ion Beam Applications SA Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant-wallon VAT : 0428.750.985 | T +32 10 47 58 11 | F +32 10 47 58 10 [email protected] | iba-worldwide.com

2

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com
For further information, please contact:
IBA Marie Sirault Paralegal +32491252480 [email protected]
Press release | 07/02/ 2022

IBA | Ion Beam Applications SA Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant-wallon VAT : 0428.750.985 | T +32 10 47 58 11 | F +32 10 47 58 10 [email protected] | iba-worldwide.com

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.